Tocolytic therapy with fenoterol induces selective down-regulation of β-adrenergic receptors in human myometrium

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 1235-1242

  Engelhardt, Stefan ^a   Zieger, Wolfgang ^b   Kassubek, Jan ^c   Michel, Martin C ^c   Lohse, Martin J ^a   Brodde, Otto Erich ^c,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Frauenklinik   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; FENOTEROL; GUANINE NUCLEOTIDE BINDING PROTEIN; MAGNESIUM SULFATE; MESSENGER RNA; METOPROLOL; PHOSPHOTRANSFERASE; RECEPTOR SUBUNIT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MYOMETRIUM; PREMATURE LABOR; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY;

ADULT; BETA-ADRENERGIC RECEPTOR KINASE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; FEMALE; FENOTEROL; GTP-BINDING PROTEINS; HUMANS; MYOMETRIUM; PREGNANCY; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; TOCOLYTIC AGENTS;

EID: 0030957619     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.4.1235     Document Type: Article

References (58)

1. Leveno KJ, Cunningham FG. 1992 β-Adrenergic agonists for preterm labor. New Engl J Med. 327:349-351.
2. The Canadian Preterm Labor Investigators Group. 1992 Treatment of preterm labor with the beta-adrenergic agonist ritodrine. New Engl J Med. 327:308-312.
3. Caritis SN. 1992 Treatment of preterm labor with the beta-adrenergic agonist ritodrine. New Engl J Med. 327:1758.
4. Schiff E, Sivan E, Terry S, et al. 1993 Currently recommended oral regimens for ritodrine tocolysis result in extremely low plasma levels. Am J Obstet Gynecol. 169:1059-1064.
5. Kosasa TS, Busse R, Wahl N, Hirata G, Nakayama RT, Hale RW. 1994 Long-term tocolysis with combined intravenous terbutaline and magnesium sulfate: a 10-year study of 1000 patients. Obstet Gynecol. 84:369-373.
6. Hausdorff WP, Caron MG, Lefkowitz RJ. 1990 Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 4:2881-2889.
7. Lohse MJ. 1993 Molecular mechanisms of membrane-receptor desensitization. Biochim Biophys Acta. 1179:171-188.
8. Lye SJ, Dayes BA, Freitag CL, Brooks J, Casper RF. 1992 Failure of ritodrine to prevent preterm labor in sheep. Am J Obstet Gynecol. 167:1399-1408.
9. Caritis SN, Chiao JP, Moore JJ, Ward SM. 1987 Myometrial desensitization after ritodrine infusion. Am J Physiol. 253:E410-E417.
10. Caritis SN, Chiao JP, Kridgen P. 1991 Comparison of pulsatile and continuous ritodrine administration: effects on uterine contractility and β-adrenergic receptor cascade. Am J Obstet Gynecol. 164:1005-1012.
11. Berg G, Andersson RGG, Ryden G. 1985 β-Adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after β-mimetic treatment. Am J Obstet Gynecol. 151:392-396.
12. Michel MC, Pingsmann A, Nohlen M, Siekmann U, Brodde O-E. 1989 Decreased myometrial beta-adrenoceptors in women receiving beta-2-adrenergic tocolytic therapy: correlation with lymphocyte beta-adrenoceptors. Clin Pharmacol Ther. 45:1-8.
13. Premont RT, Inglese J, Lefkowitz RJ. 1995 Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9:175-182.
14. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. 1990 β-Arrestin: a protein that regulates β-adrenergic receptor function. Science. 248:1547-1550.
15. Collins S, Caron MG, Lefkowitz RJ. 1991 Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression. Annu Rev Physiol. 53:497-508.
16. 2-adrenergic receptors in Chinese hamster fibroblasts. Mol Pharmacol. 41:542-548.
17. 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol. 43:548-555.
18. 2-adrenoceptor density. Eur J Pharmacol. 150:403-404.
19. Bradford MM. 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248-254.
20. Michel-Reher M, Gross G, Jasper JR, et al. 1993 Tissue- and subunit-specific regulation of G-protein expression by hypo- and hyperthyroidism. Biochem Pharmacol. 45:1417-1423.
21. Benovic JL, Mayor F, Staniszewski C, Lefkowitz RJ, Caron MG. 1987 Purification and characterization of the β-adrenergic receptor kinase. J Biol Chem. 262:9026-9032.
22. Söhlemann P, Hekman M, Buchen C, Elce JS, Lohse MJ. 1993 Purification and functional characterization of β-adrenergic receptor kinase expressed in insect cells. FEBS Lett. 324:59-62.
23. Chomczinski P, Sacchi N. 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-chloroform extraction. Anal Biochem 162:156-159.
24. Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ. 1993 Altered expression of beta-adrenergic-receptor-kinase and beta-1-adrenergic receptors in the failing human heart. Circulation. 87:454-463.
25. 1-adrenergic mRNA in heart failure. J Am Coll Cardiol. 27:146-154.
26. 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA. 84:46-50.
27. Hanauer A, Mendel JL. 1984 The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in the mouse. EMBO J 3:2627-2633.
28. Salomon Y, Londos C, Rodbell M. 1974 A highly sensitive adenylate cyclase assay. Anal Biochem. 58:541-548.
29. Brown L, Deighton NM, Bals S, et al. 1992 Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart J Cardiovasc Pharmacol. 19:222-232.
30. Katada T, Northup JK, Bokoch GM, Ui M, Gilman AG. 1984 The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Subunit dissociation and guanine nucleotide-dependent hormonal inhibition J Biol Chem. 259:3578-3585.
31. Darfler FJ, Mahan LC, Koachman AM, Insel PA. 1985 Stimulation by forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. J Biol Chem. 257:11901-11907.
32. Strittmatter S, Neer EJ. 1980 Properties of the separated catalytic and regulatory units of brain adenylate cyclase. Proc Natl Acad Sci USA 77:6344-6348.
33. Ungerer M, Parruti G, Böhm M, et al. 1994 Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circ Res. 74:206-213.
34. Brodde O-E, Michel MC, Zerkowski H-R. 1995 Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res. 30:570-584.
35. Cohn JN. 1990 Abnormalities of peripheral sympathetic nervous system control in congestive heart failure. Circulation [Suppl I]. 82:59-67.
36. Bristow MR, Ginsburg R, Minobe W, et al. 1982 Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. New Engl J Med. 307:205-211.
37. 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest. 92:2737-2745.
38. 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods J Mol Cell Cardiol. 28:1-10.
39. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev. 43:203-241.
40. Milligan G, Green A. 1991 Agonist control of G-protein levels. Trends Pharmacol Sci. 12:207-209.
41. Reithmann C, Gierschik P, Werdan K, Jakobs KH. 1991 Role of inhibitory G protein α-subunits in adenylyl cyclase desensitization. Mol Cell Endocrinol. 82:C215-C221.
42. Eschenhagen T. 1993 G proteins and the heart. Cell Biol Int. 17:723-749.
43. Wende U, Eschenhagen T, Geertz B, et al. 1992 Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart. Naunyn-Schmiedeberg's Arch Pharmacol. 345:44-50.
44. oα mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. Mol Pharmacol. 42:773-783.
45. 2-adrenoceptors in the human heart by chronic β-adrenoceptor antagonist treatment. Br J Pharmacol. 94:685-692.
46. Litime M-H, Pointis G, Breuller M, Cabrol D, Ferre F. 1989 Disappearance of β-adrenergic response of human myometrial adenylate cyclase at the end of pregnancy. J Clin Endocrinol Metab. 68:1-6.
47. i-protein alterations in human lymphocytes. J Cardiovasc Pharmacol. 20:785-789.
48. 1-adrenoceptors. J Auton Pharmacol. 13:425-438.
49. iα2. J Biol Chem. 265:14784-14790.
50. 1-adrenergic receptor mRNA levels. J Biol Chem. 266:2233-2238.
51. Bauer PH, Müller S, Puzicha M, et al. 1992 Phosducin is a protein kinase A-regulated G-protein regulator. Nature. 358:73-76.
52. Schröder S, Lohse MJ. 1996 Inhibition of G-protein βγ-subunit functions by phosducin-like protein. Proc Natl Acad Sci USA. 93:2100-2104.
53. r 35,000 protein(s) that selectively binds to β-adrenergic receptor mRNAs. J Biol Chem. 267:24103-24108.
54. Hadcock JR, Malbon CC. 1988 Down-regulation of β-adrenergic receptors: agonist-induced reduction in receptor mRNA levels. Proc Natl Acad Sci USA. 85:5021-5025.
55. Hadcock JR, Malbon CC. 1988 Regulation of β-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc Natl Acad Sci USA. 85:8415-8419.
56. Hadcock JR, Malbon CC. 1989 Agonist regulation of β-adrenergic receptor mRNA. Analysis in S49 mouse lymphoma mutants. J Biol Chem. 264:13956-13961.
57. 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem. 264:16786-16792.
58. Mahan LC, McKernan RM, Insel PA. 1987 Metabolism of alpha- and beta-adrenergic receptors in vitro and in vivo. Annu Rev Pharmacol Toxicol. 27: 215-235.